{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T12:49:06Z","timestamp":1774010946246,"version":"3.50.1"},"reference-count":33,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,1]]},"DOI":"10.1097\/mao.0b013e3181c34e53","type":"journal-article","created":{"date-parts":[[2009,12,17]],"date-time":"2009-12-17T13:38:14Z","timestamp":1261057094000},"page":"162-167","source":"Crossref","is-referenced-by-count":35,"title":["Transtympanic Steroids for M\u00e9ni\u00e8re's Disease"],"prefix":"10.1097","volume":"31","author":[{"given":"Carlos","family":"Herraiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo","family":"Plaza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jose M.","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inmaculada","family":"Gallego","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sol","family":"Marcos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-28-20210212","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S0140-6736(08)61161-7","article-title":"Meniere's disease.","volume":"372","author":"Sajjadi","year":"2008","journal-title":"Lancet"},{"key":"R2-28-20210212","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1097\/01.mao.0000185057.81962.51","article-title":"Oral administration of prednisone to control refractory vertigo in Meniere's disease: a pilot study.","volume":"26","author":"Morales-Luckie","year":"2005","journal-title":"Otol Neurotol"},{"key":"R3-28-20210212","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/S0030-6665(20)30398-4","article-title":"Dexamethasone perfusion of the labyrinth plus intravenous dexamethasone for Meniere's disease.","volume":"29","author":"Shea","year":"1996","journal-title":"Otolaryngol Clin North Am"},{"key":"R4-28-20210212","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/S0001-6519(05)78575-7","article-title":"Dexametasona via combinada intratimpatica-intravenosa para el control del vertigo en la enfermedad de Meniere.","volume":"56","author":"Garcia-Purrinos","year":"2005","journal-title":"Acta Otorrinolaringol Esp"},{"key":"R5-28-20210212","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1080\/00016480410017873","article-title":"P0 antigen detection in sudden hearing loss and Meniere's disease: a new diagnostic marker?","volume":"124","author":"Passali","year":"2004","journal-title":"Acta Otolaryngol"},{"key":"R6-28-20210212","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1177\/000348940211100704","article-title":"Induction of endolymphatic hydrops by directly infused monoclonal antibody against type II collagen CB11 peptide.","volume":"111","author":"Matsuoka","year":"2002","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R7-28-20210212","first-page":"648","article-title":"Serum antibodies against heat shock protein 70 in Meniere's disease.","volume":"16","author":"Rauch","year":"1995","journal-title":"Am J Otol"},{"key":"R8-28-20210212","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1177\/000348949710600303","article-title":"Endolymphatic sacitis in a case of active Meniere's disease. A TEM histopathological investigation.","volume":"106","author":"Danckwardt-Lilliestrom","year":"1997","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"R9-28-20210212","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0194-5998(96)70133-X","article-title":"Receptors for glucocorticoids in the human inner ear.","volume":"115","author":"Rarey","year":"1996","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R10-28-20210212","first-page":"230","article-title":"Effect of transtympanic injection of steroids on cochlear blood flow, auditory sensitivity, and histology in the guinea pig.","volume":"19","author":"Shirwany","year":"1998","journal-title":"Am J Otol"},{"key":"R11-28-20210212","first-page":"800","article-title":"Effect of stress related hormones on inner ear fluid homeostasis and function.","volume":"20","author":"Juhn","year":"1999","journal-title":"Am J Otol"},{"key":"R13-28-20210212","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/MOO.0b013e32830ce796","article-title":"Issues, indications, and controversies regarding intratympanic steroid perfusion.","volume":"16","author":"Hamid","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R14-28-20210212","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1097\/01.moo.0000244190.51560.6b","article-title":"Delivery of drugs to the inner ear.","volume":"14","author":"Hoffer","year":"2006","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R15-28-20210212","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/MOO.0b013e32830e20db","article-title":"State-of-the-art mechanisms of intracochlear drug delivery.","volume":"16","author":"Borkholder","year":"2008","journal-title":"Curr Opin Otolaryngol Head Neck Surg"},{"key":"R16-28-20210212","first-page":"181","article-title":"American Academy of Otolaryngology-Head Neck Surgery Foundation, Inc.","volume":"113","year":"1995","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R17-28-20210212","first-page":"170","article-title":"Long-term progression of Meniere's disease.","volume":"10","author":"Stahle","year":"1989","journal-title":"Am J Otol"},{"key":"R18-28-20210212","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1001\/archotol.130.4.431","article-title":"Progression of symptoms of dizziness in Meniere's disease.","volume":"130","author":"Havia","year":"2004","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R19-28-20210212","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1001\/archotol.134.11.1149","article-title":"Time course of episodes of definitive vertigo in Meniere's disease.","volume":"134","author":"Perez-Garrigues","year":"2008","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"R20-28-20210212","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1159\/000049079","article-title":"Short-term outcome and prognosis of acute low-tone sensorineural hearing loss by administration of steroid.","volume":"64","author":"Fuse","year":"2002","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R21-28-20210212","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005537-199907001-00001","article-title":"Corticosteroid pharmacokinetics in the inner ear fluids: an animal study followed by clinical application.","volume":"109","author":"Parnes","year":"1999","journal-title":"Laryngoscope"},{"key":"R22-28-20210212","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1097\/00005537-199811000-00017","article-title":"Hearing results of intratympanic steroid treatment of endolymphatic hydrops.","volume":"108","author":"Arriaga","year":"1998","journal-title":"Laryngoscope"},{"key":"R23-28-20210212","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1017\/S0022215100143610","article-title":"Transtympanic dexamethasone application in Meniere's disease: an alternative treatment for intractable vertigo.","volume":"113","author":"Sennaroglu","year":"1999","journal-title":"J Laryngol Otol"},{"key":"R24-28-20210212","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1159\/000027730","article-title":"Intratympanic and systemic dexamethasone for Meniere's disease.","volume":"62","author":"Hirvonen","year":"2000","journal-title":"ORL J Otorhinolaryngol Relat Spec"},{"key":"R25-28-20210212","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1097\/00005537-200112000-00003","article-title":"Intratympanic steroid injections for intractable Meniere's disease.","volume":"111","author":"Barrs","year":"2001","journal-title":"Laryngoscope"},{"key":"R26-28-20210212","doi-asserted-by":"crossref","first-page":"617","DOI":"10.3109\/00016489109131486","article-title":"Treatment of vestibular disorders.","volume":"481","author":"Itoh","year":"1991","journal-title":"Acta Otolaryngol Suppl"},{"key":"R27-28-20210212","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1067\/mhn.2001.119485","article-title":"Intratympanic dexamethasone, intratympanic gentamicin, and endolymphatic sac surgery for intractable vertigo in Meniere's disease.","volume":"125","author":"Sennaroglu","year":"2001","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R28-28-20210212","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1097\/00005537-200311000-00008","article-title":"Intratympanic steroids: do they acutely improve hearing in cases of cochlear hydrops?","volume":"113","author":"Hillman","year":"2003","journal-title":"Laryngoscope"},{"key":"R29-28-20210212","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1097\/01.mlg.0000147919.89357.16","article-title":"Intratympanic injections of dexamethasone for long-term control of vertigo.","volume":"114","author":"Barrs","year":"2004","journal-title":"Laryngoscope"},{"key":"R30-28-20210212","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1177\/014556130408300611","article-title":"Intratympanic steroid perfusion for the treatment of Meniere's disease: a retrospective study.","volume":"83","author":"Dodson","year":"2004","journal-title":"Ear Nose Throat J"},{"key":"R31-28-20210212","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1097\/01.mao.0000185050.69394.48","article-title":"Intratympanic dexamethasone and hyaluronic acid in patients with low-frequency and Meniere's-associated sudden sensorineural hearing loss.","volume":"26","author":"Selivanova","year":"2005","journal-title":"Otol Neurotol"},{"key":"R32-28-20210212","first-page":"196","article-title":"Dexamethasone inner ear perfusion for the treatment of Meniere's disease: a prospective, randomized, double-blind, crossover trial.","volume":"19","author":"Silverstein","year":"1998","journal-title":"Am J Otol"},{"key":"R33-28-20210212","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.otohns.2005.05.010","article-title":"Dexamethasone inner ear perfusion by intratympanic injection in unilateral Meniere's disease: a two-year prospective, placebo-controlled, double-blind, randomized trial.","volume":"133","author":"Garduno-Anaya","year":"2005","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R34-28-20210212","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/mao.0b013e31815dbafc","article-title":"Longitudinal results with intratympanic dexamethasone in the treatment of Meniere's disease.","volume":"29","author":"Boleas-Aguirre","year":"2008","journal-title":"Otol Neurotol"}],"container-title":["Otology & Neurotology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MAO.0b013e3181c34e53","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:45:41Z","timestamp":1620960341000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00129492-201001000-00028"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,1]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/mao.0b013e3181c34e53","relation":{},"ISSN":["1531-7129"],"issn-type":[{"value":"1531-7129","type":"print"}],"subject":[],"published":{"date-parts":[[2010,1]]}}}